Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03418662 · ClinicalTrials.gov registry record · NA
EndoRings Colonoscopy vs Standard Colonoscopy
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 592
- Enrollment target
NCT03418662: Completed NA study, sponsored by Indiana University.
NCT03418662 is a NA study that has completed, run by Indiana University. The registered enrollment target is 592 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03418662, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 592 participants
- Enrollment target
Study Summary
The study aims to compare the results between a standard colonoscopy to a colonoscopy with an attachment on the distal end of the colonoscope.
Primary Outcome
Number of participants with at least one adenoma detected, during Standard Colonoscopy compared with colonoscopy with EndoRings.
Interventions
- DEVICE EndoRings device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 592 participants |
| Start Date | 2018-01-19 |
| Est. Completion | 2018-09-13 |
| Phase | NA |
What the finished NCT03418662 record still lists
NCT03418662 is an interventional study that assigns participants to a tested intervention. The registered 592 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 1 intervention - of which EndoRings device is the first listed.
NCT03418662 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03418662 about?
NCT03418662 is a clinical study titled "EndoRings Colonoscopy vs Standard Colonoscopy". The study aims to compare the results between a standard colonoscopy to a colonoscopy with an attachment on the distal end of the colonoscope.
What is the current status of trial NCT03418662?
This trial is currently completed. It is a NA study. The enrollment target is 592 participants. The study started on 2018-01-19. Estimated completion is 2018-09-13.
What interventions are being tested in trial NCT03418662?
The interventions under investigation include: EndoRings device (DEVICE).
Who is sponsoring clinical trial NCT03418662?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03418662's enrollment target sits among peer trials
592 175th of 2000 higher than 1,826 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04701684 · 594 participants · NA
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
- NCT05491213 · 594 participants · NA
TELESCOPE- TELEhealth Shared Decision-making COaching
- NCT05867420 · 594 participants · Phase 1
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
- NCT06890884 · 594 participants · Phase 2
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI